According to Nevro 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.04196. At the end of 2022 the company had a P/E ratio of 566.
Year | P/E ratio | Change |
---|---|---|
2022 | 566 | -2730.74% |
2021 | -21.5 | -69.07% |
2020 | -69.5 | 99.91% |
2019 | -34.8 | 45.75% |
2018 | -23.9 | -56.46% |
2017 | -54.8 | -15.54% |
2016 | -64.9 | 145.05% |
2015 | -26.5 | 1431.06% |
2014 | -1.73 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
![]() | 114 | -5,686.15% | ๐บ๐ธ USA |
![]() | 64.8 | -3,273.39% | ๐บ๐ธ USA |
![]() | 28.6 | -1,500.44% | ๐บ๐ธ USA |
![]() | -3.73 | 82.64% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.